Osaic Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92K Sell
965
-17
-2% -$1.81K ﹤0.01% 5069
2026
Q2
$109K Sell
982
-57
-5% -$5.15K ﹤0.01% 4879
2026
Q1
$90.4K Hold
1,039
– – ﹤0.01% 4900
2025
Q4
$111K Buy
1,039
+59
+6% +$6.26K ﹤0.01% 4620
2025
Q3
$100K Buy
980
+1
+0.1% +$93 ﹤0.01% 4781
2025
Q2
$61.9K Buy
979
+389
+66% +$23.8K ﹤0.01% 4895
2025
Q1
$31.3K Sell
590
-83
-12% -$4.6K ﹤0.01% 5045
2024
Q4
$37.7K Buy
673
+5
+0.7% +$276 ﹤0.01% 4904
2024
Q3
$35K Sell
668
-492
-42% -$23.6K ﹤0.01% 5001
2024
Q2
$47.6K Buy
1,160
+432
+59% +$17.2K ﹤0.01% 4719
2024
Q1
$31.5K Buy
728
+519
+248% +$22.7K ﹤0.01% 5068
2023
Q4
$9.6K Hold
209
– – ﹤0.01% 5853
2023
Q3
$4.79K Sell
209
-40
-16% -$896 ﹤0.01% 6292
2023
Q2
$4.1K Buy
249
+40
+19% +$722 ﹤0.01% 6398
2023
Q1
$3.73K Hold
209
– – ﹤0.01% 6476
2022
Q4
$6K Hold
209
– – ﹤0.01% 6216
2022
Q3
$5K Sell
209
-1
-0.5% -$19 ﹤0.01% 6386
2022
Q2
$1K Hold
210
– – ﹤0.01% 7140
2022
Q1
$2K Hold
210
– – ﹤0.01% 6909
2021
Q4
$2K Sell
210
-600
-74% -$6.74K ﹤0.01% 7048
2021
Q3
$11K Sell
810
-105
-11% -$1.6K ﹤0.01% 6156
2021
Q2
$18K Sell
915
-80
-8% -$1.66K ﹤0.01% 5730
2021
Q1
$21K Buy
995
+45
+5% +$1.3K ﹤0.01% 5441
2020
Q4
$28K Buy
950
+75
+9% +$1.91K ﹤0.01% 4955
2020
Q3
$19K Buy
875
+675
+338% +$15.5K ﹤0.01% 4948
2020
Q2
$4K Hold
200
– – ﹤0.01% 5585
2020
Q1
$3K Buy
+200
New +$3.58K ﹤0.01% 5569

Other funds holding RYTM

Osaic Holdings's RYTM Position: Q3 2026 in Review

Osaic Holdings reduced its Rhythm Pharmaceuticals (RYTM) stake by 1.7% in Q3 2026, selling an estimated $1.81K and leaving 965 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #5069.

Osaic Holdings first reported a position in RYTM in Q1 2020 and has held it in 27 quarters since. The position peaked at $111K in Q4 2025. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Osaic Holdings held 965 shares of Rhythm Pharmaceuticals worth $92K as of Q3 2026.
  • Osaic Holdings sold 17 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $1.81K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5069 holding.
  • Osaic Holdings first reported a position in Rhythm Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
  • Osaic Holdings's Rhythm Pharmaceuticals position peaked at $111K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.